Advertisement
Thursday, November 19, 2026NewslettersAdvertiseWatch FL1
GET LOCALGo ad-freeHigh school sportsLocal eventsObituaries
Uncategorized

Merck’s COVID-19 treatment pill has been approved in one country

Merck’s COVID-19 treatment pill has been approved in one country

On Thursday, United State’s company Merck has their antiviral medication used to treat COVID-19 approved in the United Kingdom.

The pill was approved in an attempt to fight the outbreak currently happening throughout the country.

The drug, molnupiravir, was suggested to be used for those with mild to moderate cases of COVID-19 with one risk factor that could cause issues like obesity or diabetes.


The drug will be given to a person after they test positive within 5 days of showing symptoms.

The U.S. will consider approving the drug next month.

The drug has been submitted to the FDA by Merck and is compared to Tamiflu, a common medication used to treat flu symptoms.

The former commissioner of the FDA, Dr. Scott Gottlieb, said the pill could get society out of the pandemic phase of the outbreak.

Related: Merck applies for FDA emergency use authorization for its COVID-19 pill

Want to go ad-free?

Become an FL1 member and say goodbye to ads! Plus, you’ll be supporting a company rooted in the Finger Lakes for nearly 30 years.

$4.99 / month

Get ad-free access

Renews monthly. Cancel anytime through your account. Already contributing via Google? Sign in with your Google account and unlock ad-free access. Embedded YouTube videos and other third-party media players may still contain ads.

Start your day with FingerLakes1

Get the stories that matter from across the Finger Lakes, delivered to your inbox.

Your email will be added to our newsletter mailing list, hosted on Substack. Privacy policy